Abstract
Patients with malignancy, who are unable to meet their nutritional needs through oral or enteral routes, and who have at least a 3-months prognosis and good performance status, should be considered for Home Parenteral Nutrition (HPN)1. The number of patients with cancer receiving HPN in the UK is rising. Given the increase in utilisation, it is important to evaluate response to treatment and ensure robust decision making is in place. This audit aimed to review the outcomes of patients commenced on palliative HPN for this indication in our centre.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
